Generic placeholder image

Pharmaceutical Nanotechnology

Author(s): Bhumika Kumar*, P.K. Sahoo and Satish Manchanda

DOI: 10.2174/2211738509666210208225826

DownloadDownload PDF Flyer Cite As
Curcumin Loaded Ethosomal Gel for Improved Topical Delivery: Formulation, Characterization and Ex-vivo Studies

Page: [281 - 287] Pages: 7

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Background: Curcumin is a curcuminoid, which is an active constituent of turmeric and is obtained from the rhizomes of Curcuma longa, family Zingiberaceae. Curcumin modulates the activity of various transcription factors and regulates the expression of inflammatory enzymes, cell survival proteins, adhesion molecules and cytokines by binding to a variety of proteins and inhibiting the activity of various kinases. Curcumin falls in the BCS class IV drug, with poor solubility and poor permeability which makes it very challenging to utilize the maximum therapeutic potential of this moiety

Objective: The major aim of the study was to enhance transdermal penetration of curcumin via ethosomal gel and to overcome the barriers of poor permeability of transdermal drug delivery.

Methods: Curcumin loaded ethosomes were prepared with varying quantities of ethanol and soya lecithin by the cold method and were optimised based on entrapment efficiency, vesicular size and Ex-vivo studies. Optimised ethosomal formulation was further incorporated into a gel and was evaluated. Ex-vivo studies were performed with the ethosomal gel of curcumin and was compared with simple drug solution.

Results: Prepared ethosomal system showed a vesicle size ranging from 211 to 320 nm with spherical, smooth surface and entrapment efficiency of 87 to 91%. Optimised ethosomal system (ET3) was incorporated into gel and was further evaluated.

Conclusion: The findings of the research work suggested that the ethosomal gel holds excellent potential for transdermal delivery of curcumin.

Keywords: Curcumin, Ethosomes, Ethosomal gel, Ex-Vivo studies, Topical delivery, skin

Graphical Abstract

[1]
Ammon HP, Wahl MA. Pharmacology of Curcuma longa. Planta Med 1991; 57(1): 1-7.
[http://dx.doi.org/10.1055/s-2006-960004] [PMID: 2062949]
[2]
Eigner D, Scholz D. Ferula asa-foetida and Curcuma longa in traditional medical treatment and diet in Nepal. J Ethnopharmacol 1999; 67(1): 1-6.
[http://dx.doi.org/10.1016/S0378-8741(98)00234-7] [PMID: 10616954]
[3]
Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R. Anti-tumour and antioxidant activity of natural curcuminoids. Cancer Lett 1995; 94(1): 79-83.
[http://dx.doi.org/10.1016/0304-3835(95)03827-J] [PMID: 7621448]
[4]
Harsh M. Textbook of Pathology(5th ed). New Delhi: Medical Publisher Ltd 2006; pp. 802-3.
[5]
Chattopadhya I, Biswas K, Bandoyopadhyay U, Bannerjee RK. Turmeric and curcumin: biological action and medical applications. Curr Sci 2004; 87(1): 44-53.
[6]
Anand P, Thomas SG, Kunnumakkara AB, et al. Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature. Biochem Pharmacol 2008; 76(11): 1590-611.
[http://dx.doi.org/10.1016/j.bcp.2008.08.008] [PMID: 18775680]
[7]
Kumar BA, Aggarwal R, Prakash U, et al. Potential role of curcumin in amelioration of skin diseases: a comprehensive review. Curr Tradit Med 2020; 6: 1.
[http://dx.doi.org/10.2174/2215083806999201123202531]
[8]
Liu W, Zhai Y, Heng X, et al. Oral bioavailability of curcumin: problems and advancements. J Drug Targ 2016; 24(8): 694-702.
[9]
Enhanced transdermal drug penetration of curcumin via ethosomes Malays J Pharm Sci 2013; 11(1): 48-58.
[10]
Gupta A, Mishra AK, Singh AK, et al. Formulation and evaluation of topical gel of diclofenac sodium using different polymers. Drug Invention Today 2010; 2(Suppl. 5): 250-3.
[11]
Khandre P. Formulation and evaluation studies on nimesulide topical gel pHD dissertation. India: Rajiv Gandhi University of Health Sciences 2010.
[12]
Mistry A, Ravikumar P, Pathare S. Ethosomes: unique elastic vesicular carrier - an overview. Int J Pharm Sci Res 2015; 6(10): 4129-36.
[13]
Touitou E, Godin B, Weiss C. Enhanced delivery of drug into and across the skin by ethosomal carrier. Drug Dev Res 2000; 50: 406-15.
[http://dx.doi.org/10.1002/1098-2299(200007/08)50:3/4<406::AID-DDR23>3.0.CO;2-M]
[14]
Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. J Adv Pharm Technol Res 2010; 1(3): 274-82.
[http://dx.doi.org/10.4103/0110-5558.72415] [PMID: 22247858]
[15]
Li G, Fan Y, Fan C, et al. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm 2012; 82(1): 49-57.
[http://dx.doi.org/10.1016/j.ejpb.2012.05.011] [PMID: 22705640]
[16]
Parashar T. Ethosomes: a recent vesicle of transdermal drug delivery system. Int J Res Develop Pharm Life Sci 2013; 2(2): 285-92.
[17]
Jin-guang C, Wei L, Yu J. Preparation of curcumin ethosomes. Afr J Pharm Pharmacol 2013; 7(31): 246-2251.
[http://dx.doi.org/10.5897/AJPP12.435]
[18]
Anwer MK, Al-Mansoor MA, Jamil S, Al-Shdefat R, Ansari MN, Shakeel F. Development and evaluation of PLGA polymer based nanoparticles of quercetin. Int J Biol Macromol 2016; 92: 213-9.
[http://dx.doi.org/10.1016/j.ijbiomac.2016.07.002] [PMID: 27381585]
[19]
Zhang YT, Shen LN, Zhao JH, Feng NP. Evaluation of psoralen ethosomes for topical delivery in rats by using in vivo microdialysis. Int J Nanomedicine 2014; 9: 669-78.
[http://dx.doi.org/10.2147/IJN.S57314] [PMID: 24489470]
[20]
Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S. Nanoemulsions as vehicles for transdermal delivery of aceclofenac. AAPS PharmSciTech 2007; 8(4): E104.
[http://dx.doi.org/10.1208/pt0804104] [PMID: 18181525]
[21]
Gray GM, Yardley HJ. Lipid compositions of cells isolated from pig, human, and rat epidermis. J Lipid Res 1975; 16(6): 434-40.
[http://dx.doi.org/10.1016/S0022-2275(20)34493-X] [PMID: 1194786]
[22]
Wester RC, Melendres J, Sedik L, Maibach H, Riviere JE. Percutaneous absorption of salicylic acid, theophylline, 2, 4-dimethylamine, diethyl hexyl phthalic acid, and p-aminobenzoic acid in the isolated perfused porcine skin flap compared to man in vitro. Toxicol Appl Pharmacol 1998; 151(1): 159-65.
[http://dx.doi.org/10.1006/taap.1998.8434] [PMID: 9705899]
[23]
Herkenne C, Naik A, Kalia YN, Hadgraft J, Guy RH. Pig ear skin ex vivo as a model for in vivo dermatopharmacokinetic studies in man. Pharm Res 2006; 23(8): 1850-6.
[http://dx.doi.org/10.1007/s11095-006-9011-8] [PMID: 16841197]
[24]
Ashok A Hajare, Mahesh N Mali, Sushil Sarvagod, et al. Adsorption and partition studies of fluconazole. Asian J Res Chem 2009; 2(2): 213-9.
[25]
Shivhare UD, Jain KB, Mathur VB, Bhusari KP, Roy AA. Formulation development and evaluation of diclofenac sodium gel using water soluble polyacrylamide polymer. Dig J Nanomater Biostruct 2009; 4(Suppl. 2): 285-90.
[26]
Indora N, Kaushik D. Design, development and evaluation of ethosomal gel of fluconazole for topical fungal infection. Int J Eng Sci Inv Res Dev 2015; 1(8): 281-306.
[27]
Chandra A, Aggarwal G, Manchanda S, Narula A. Development of topical gel of methotrexate incorporated ethosomes and salicylic acid for the treatment of psoriasis. Pharm Nanotechnol 2019; 7(5): 362-74.
[http://dx.doi.org/10.2174/2211738507666190906123643] [PMID: 31490769]
[28]
Sujitha B, Krishnamoorthy B, Muthukumaran M. Formulation and evaluation of piroxicam loaded ethosomal gel for transdermal delivery. Int J Adv Pharm Gen Res 2014; 2: 34-45.